{"id":"https://openalex.org/W4367602020","doi":"https://doi.org/10.1158/1078-0432.ccr-22-2595","title":"Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II Trial","display_name":"Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II Trial","alternate_titles":[],"publication_year":2023,"publication_date":"2023-05-01","ids":{"openalex":"https://openalex.org/W4367602020","doi":"https://doi.org/10.1158/1078-0432.ccr-22-2595","pmid":"https://pubmed.ncbi.nlm.nih.gov/37126016","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10390884"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-22-2595","doi":"https://doi.org/10.1158/1078-0432.ccr-22-2595","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-22-2595","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/doi/10.1158/1078-0432.CCR-22-2595/3343764/ccr-22-2595.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4367602020"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://aacrjournals.org/clincancerres/article-pdf/doi/10.1158/1078-0432.CCR-22-2595/3343764/ccr-22-2595.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074884103","display_name":"Oliver Dorigo","orcid":"https://orcid.org/0000-0002-1976-5201","observed_orcids":["https://orcid.org/0000-0002-1976-5201","https://orcid.org/0000-0002-5749-2742"]},"institutions":[{"id":"https://openalex.org/I4390039303","display_name":"Stanford Cancer Institute","ror":"https://ror.org/014qe3j22","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I4390039303","https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Oliver Dorigo","raw_affiliation_strings":["1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford Cancer Institute, Stanford, California"],"raw_orcid":"https://orcid.org/0000-0002-1976-5201","affiliations":[{"raw_affiliation_string":"1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford Cancer Institute, Stanford, California","institution_ids":["https://openalex.org/I4390039303"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072712459","display_name":"Amit M. Oza","orcid":"https://orcid.org/0000-0002-9510-8641","observed_orcids":["https://orcid.org/0000-0002-9510-8641"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Amit M. Oza","raw_affiliation_strings":["2Medical Oncology & Hematology, Princess Margaret Hospital Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada"],"raw_orcid":"https://orcid.org/0000-0002-9510-8641","affiliations":[{"raw_affiliation_string":"2Medical Oncology & Hematology, Princess Margaret Hospital Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I185261750","https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069625939","display_name":"Tanja B. Pejovic","orcid":"https://orcid.org/0000-0001-8537-1086","observed_orcids":["https://orcid.org/0000-0001-8537-1086"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tanja Pejovic","raw_affiliation_strings":["3Department of Obstetrics and Gynecology, and Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon"],"raw_orcid":"https://orcid.org/0000-0001-8537-1086","affiliations":[{"raw_affiliation_string":"3Department of Obstetrics and Gynecology, and Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044874564","display_name":"Prafull Ghatage","orcid":"https://orcid.org/0000-0002-2371-0844","observed_orcids":["https://orcid.org/0000-0002-2371-0844"]},"institutions":[{"id":"https://openalex.org/I168635309","display_name":"University of Calgary","ror":"https://ror.org/03yjb2x39","country_code":"CA","type":"education","lineage":["https://openalex.org/I168635309"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Prafull Ghatage","raw_affiliation_strings":["4Division of Gynecologic Oncology, Department of Oncology, University of Calgary, Calgary, Alberta, Canada"],"raw_orcid":"https://orcid.org/0000-0002-2371-0844","affiliations":[{"raw_affiliation_string":"4Division of Gynecologic Oncology, Department of Oncology, University of Calgary, Calgary, Alberta, Canada","institution_ids":["https://openalex.org/I168635309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049011165","display_name":"Sharad A. Ghamande","orcid":"https://orcid.org/0000-0003-2242-2215","observed_orcids":["https://orcid.org/0000-0003-2242-2215"]},"institutions":[{"id":"https://openalex.org/I25041050","display_name":"Augusta University","ror":"https://ror.org/012mef835","country_code":"US","type":"education","lineage":["https://openalex.org/I25041050"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sharad Ghamande","raw_affiliation_strings":["5Department of Obstetrics and Gynecology, Medical College of Georgia, Augusta University, Augusta, Georgia"],"raw_orcid":"https://orcid.org/0000-0003-2242-2215","affiliations":[{"raw_affiliation_string":"5Department of Obstetrics and Gynecology, Medical College of Georgia, Augusta University, Augusta, Georgia","institution_ids":["https://openalex.org/I25041050"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020493456","display_name":"Diane Michele Provencher","orcid":"https://orcid.org/0000-0003-1902-3256","observed_orcids":["https://orcid.org/0000-0003-1902-3256"]},"institutions":[{"id":"https://openalex.org/I70931966","display_name":"Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0161xgx34","country_code":"CA","type":"education","lineage":["https://openalex.org/I70931966"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Diane Provencher","raw_affiliation_strings":["6Department of Obstetrics-Gynecology, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"],"raw_orcid":"https://orcid.org/0000-0003-1902-3256","affiliations":[{"raw_affiliation_string":"6Department of Obstetrics-Gynecology, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada","institution_ids":["https://openalex.org/I70931966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062800449","display_name":"Lisa Diana MacDonald","orcid":"https://orcid.org/0000-0003-4024-8214","observed_orcids":["https://orcid.org/0000-0003-4024-8214"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lisa D. MacDonald","raw_affiliation_strings":["7IMV Inc., Dartmouth, Nova Scotia, Canada"],"raw_orcid":"https://orcid.org/0000-0003-4024-8214","affiliations":[{"raw_affiliation_string":"7IMV Inc., Dartmouth, Nova Scotia, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021526137","display_name":"Heather Torrey","orcid":"https://orcid.org/0000-0003-4278-6411","observed_orcids":["https://orcid.org/0000-0003-4278-6411"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Heather Torrey","raw_affiliation_strings":["7IMV Inc., Dartmouth, Nova Scotia, Canada"],"raw_orcid":"https://orcid.org/0000-0003-4278-6411","affiliations":[{"raw_affiliation_string":"7IMV Inc., Dartmouth, Nova Scotia, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075958765","display_name":"Valarmathy Kaliaperumal","orcid":"https://orcid.org/0000-0001-6131-8678","observed_orcids":["https://orcid.org/0000-0001-6131-8678"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Valarmathy Kaliaperumal","raw_affiliation_strings":["7IMV Inc., Dartmouth, Nova Scotia, Canada"],"raw_orcid":"https://orcid.org/0000-0001-6131-8678","affiliations":[{"raw_affiliation_string":"7IMV Inc., Dartmouth, Nova Scotia, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035624027","display_name":"Walead Ebrahimizadeh","orcid":"https://orcid.org/0000-0002-4954-2738","observed_orcids":["https://orcid.org/0000-0002-4954-2738"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Walead Ebrahimizadeh","raw_affiliation_strings":["7IMV Inc., Dartmouth, Nova Scotia, Canada"],"raw_orcid":"https://orcid.org/0000-0002-4954-2738","affiliations":[{"raw_affiliation_string":"7IMV Inc., Dartmouth, Nova Scotia, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033635354","display_name":"Heather Anne Hirsch","orcid":"https://orcid.org/0000-0002-9917-3483","observed_orcids":["https://orcid.org/0000-0002-9917-3483"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Heather A. Hirsch","raw_affiliation_strings":["7IMV Inc., Dartmouth, Nova Scotia, Canada"],"raw_orcid":"https://orcid.org/0000-0002-9917-3483","affiliations":[{"raw_affiliation_string":"7IMV Inc., Dartmouth, Nova Scotia, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035803590","display_name":"Yogesh M. Bramhecha","orcid":"https://orcid.org/0000-0002-6888-7301","observed_orcids":["https://orcid.org/0000-0002-6888-7301"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yogesh Bramhecha","raw_affiliation_strings":["7IMV Inc., Dartmouth, Nova Scotia, Canada"],"raw_orcid":"https://orcid.org/0000-0002-6888-7301","affiliations":[{"raw_affiliation_string":"7IMV Inc., Dartmouth, Nova Scotia, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038190564","display_name":"Jeannine Villella","orcid":"https://orcid.org/0000-0001-7156-352X","observed_orcids":["https://orcid.org/0000-0001-7156-352X"]},"institutions":[{"id":"https://openalex.org/I1302444339","display_name":"Northwell Health","ror":"https://ror.org/02bxt4m23","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1302444339"]},{"id":"https://openalex.org/I2800628709","display_name":"Lenox Hill Hospital","ror":"https://ror.org/0231d2y50","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1302444339","https://openalex.org/I2800628709"]},{"id":"https://openalex.org/I4210106353","display_name":"Donald & Barbara Zucker School of Medicine at Hofstra/Northwell","ror":"https://ror.org/01ff5td15","country_code":"US","type":"education","lineage":["https://openalex.org/I1302444339","https://openalex.org/I139290212","https://openalex.org/I4210106353"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeannine Villella","raw_affiliation_strings":["8Division of Gynecologic Oncology, Lenox Hill Hospital/Northwell Health Cancer Institute, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, New York"],"raw_orcid":"https://orcid.org/0000-0001-7156-352X","affiliations":[{"raw_affiliation_string":"8Division of Gynecologic Oncology, Lenox Hill Hospital/Northwell Health Cancer Institute, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, New York","institution_ids":["https://openalex.org/I1302444339","https://openalex.org/I2800628709","https://openalex.org/I4210106353"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064736890","display_name":"Stephan Fiset","orcid":"https://orcid.org/0009-0006-0361-0375","observed_orcids":["https://orcid.org/0009-0006-0361-0375"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephan Fiset","raw_affiliation_strings":["7IMV Inc., Dartmouth, Nova Scotia, Canada"],"raw_orcid":"https://orcid.org/0009-0006-0361-0375","affiliations":[{"raw_affiliation_string":"7IMV Inc., Dartmouth, Nova Scotia, Canada","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":12,"corresponding_author_ids":["https://openalex.org/A5074884103"],"corresponding_institution_ids":["https://openalex.org/I4390039303"],"apc_list":null,"apc_paid":null,"fwci":1.9986,"has_fulltext":true,"cited_by_count":17,"citation_normalized_percentile":{"value":0.88001682,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"29","issue":"15","first_page":"2808","last_page":"2815"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/recurrent-ovarian-cancer","display_name":"recurrent ovarian cancer","score":0.824999988079071},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.4659999907016754},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.925000011920929},{"id":"https://openalex.org/keywords/platinum-resistant-ovarian-cancer","display_name":"platinum-resistant ovarian cancer","score":0.847000002861023},{"id":"https://openalex.org/keywords/platinum-sensitive-ovarian-cancer","display_name":"platinum-sensitive ovarian cancer","score":0.824999988079071},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.7350000143051147},{"id":"https://openalex.org/keywords/disease-control-rate","display_name":"disease control rate","score":0.9100000262260437},{"id":"https://openalex.org/keywords/treatment-related-adverse-events","display_name":"treatment-related adverse events","score":0.753000020980835}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8957566022872925},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6656081676483154},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.623989462852478},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.5261677503585815},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5260279774665833},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.5050464272499084},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4859067499637604},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.48150405287742615},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.46421292424201965},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.4586707353591919},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.43992218375205994},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4230548143386841},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4163539409637451},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.40095070004463196},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.39002856612205505},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077216","descriptor_name":"Carcinoma, Ovarian Epithelial","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D010984","descriptor_name":"Platinum","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.ccr-22-2595","doi":"https://doi.org/10.1158/1078-0432.ccr-22-2595","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-22-2595","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/doi/10.1158/1078-0432.CCR-22-2595/3343764/ccr-22-2595.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10390884","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10390884","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10390884/pdf/2808.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Cancer Res","raw_type":"Text"},{"id":"pmid:37126016","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37126016","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Randomized Controlled Trial"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.ccr-22-2595","doi":"https://doi.org/10.1158/1078-0432.ccr-22-2595","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-22-2595","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/doi/10.1158/1078-0432.CCR-22-2595/3343764/ccr-22-2595.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4367602020.pdf","grobid_xml":"https://content.openalex.org/works/W4367602020.grobid-xml"},"referenced_works_count":49,"referenced_works":["https://openalex.org/W104750606","https://openalex.org/W1523461418","https://openalex.org/W1540060031","https://openalex.org/W1602732985","https://openalex.org/W1918156452","https://openalex.org/W1968525251","https://openalex.org/W1973091654","https://openalex.org/W1990675339","https://openalex.org/W2002710053","https://openalex.org/W2012505533","https://openalex.org/W2024039874","https://openalex.org/W2041056208","https://openalex.org/W2072059383","https://openalex.org/W2078852869","https://openalex.org/W2080943490","https://openalex.org/W2108177250","https://openalex.org/W2119478570","https://openalex.org/W2137074525","https://openalex.org/W2138215232","https://openalex.org/W2147622445","https://openalex.org/W2150663100","https://openalex.org/W2168920981","https://openalex.org/W2231156824","https://openalex.org/W2296049142","https://openalex.org/W2345394027","https://openalex.org/W2396289154","https://openalex.org/W2527905628","https://openalex.org/W2572174216","https://openalex.org/W2624915196","https://openalex.org/W2781863615","https://openalex.org/W2788656587","https://openalex.org/W2792511820","https://openalex.org/W2797967795","https://openalex.org/W2802155618","https://openalex.org/W2804711363","https://openalex.org/W2890261294","https://openalex.org/W2911940503","https://openalex.org/W2972524777","https://openalex.org/W3004954919","https://openalex.org/W3033443551","https://openalex.org/W3092122627","https://openalex.org/W3094922645","https://openalex.org/W3095487872","https://openalex.org/W3105357800","https://openalex.org/W3108804421","https://openalex.org/W3128646645","https://openalex.org/W3155656454","https://openalex.org/W3162975920","https://openalex.org/W3214232282"],"related_works":["https://openalex.org/W4322011869","https://openalex.org/W4392376557","https://openalex.org/W4281682739","https://openalex.org/W7161055427","https://openalex.org/W4386948667","https://openalex.org/W4394011134","https://openalex.org/W2947929331","https://openalex.org/W2890998636","https://openalex.org/W4362544124","https://openalex.org/W1700249410"],"abstract_inverted_index":{"PURPOSE:":[0],"Patients":[1],"with":[2,43,47,133,148,227,232,238,243],"platinum-resistant":[3,176],"ovarian":[4,49,245],"cancer":[5],"respond":[6],"poorly":[7],"to":[8,35,65,88,185],"existing":[9],"therapies.":[10],"Hence":[11],"there":[12],"is":[13,26,236],"a":[14,27,134],"need":[15],"for":[16,53,241],"more":[17],"effective":[18],"treatments.":[19],"PATIENTS":[20],"AND":[21],"METHODS:":[22],"The":[23,160],"DeCidE1":[24],"trial":[25],"multicenter,":[28],"randomized,":[29],"open-label,":[30],"single-arm":[31],"phase":[32],"II":[33],"study":[34],"evaluate":[36],"the":[37,118,121,175,252],"safety":[38],"and":[39,102,155,170,196,214],"effectiveness":[40],"of":[41,72,139,199,251],"maveropepimut-S":[42,75],"cyclophosphamide":[44,235],"in":[45,98,174,224],"patients":[46,107,147,180,226,242],"recurrent":[48,244],"cancer.":[50,246],"Median":[51,110],"follow-up":[52],"evaluable":[54,119],"subjects":[55,210],"was":[56,96,112,126,172],"4.4":[57],"months.":[58,187],"Data":[59],"were":[60,108,162,193,205,222],"collected":[61],"from":[62],"March":[63],"2019":[64],"June":[66],"2021.":[67],"Subjects":[68],"received":[69],"two":[70],"injections":[71],"0.25":[73],"mL":[74],"3":[76,213],"weeks":[77,86],"apart,":[78],"followed":[79],"by":[80],"one":[81],"0.1-mL":[82],"doses,":[83],"every":[84],"8":[85,151],"up":[87,184],"progression.":[89],"Oral":[90],"cyclophosphamide,":[91],"50":[92],"mg":[93],"twice":[94],"daily,":[95],"administered":[97],"repeating":[99],"weekly":[100],"on":[101,167],"off":[103],"cycles.":[104],"RESULTS:":[105],"Twenty-two":[106],"enrolled.":[109],"age":[111],"58":[113],"years":[114],"(38-78":[115],"years).":[116],"Among":[117],"population,":[120],"objective":[122],"response":[123],"rate":[124,137],"(ORR)":[125],"21%":[127],"[90%":[128],"confidence":[129],"interval":[130],"(CI),":[131],"7.5%-41.9%],":[132],"disease":[135],"control":[136],"(DCR)":[138],"63%":[140],"(90%":[141],"CI,":[142],"41.8%-81.3%),":[143],"including":[144],"4":[145,217],"(21%)":[146],"partial":[149],"responses,":[150],"(42%)":[152],"stable":[153],"disease,":[154],"7":[156],"(37%)":[157],"progressive":[158],"disease.":[159],"ORRs":[161],"consistent":[163],"across":[164],"subgroups":[165],"based":[166],"platinum":[168,253],"sensitivity,":[169],"DCR":[171],"higher":[173],"subpopulation.":[177],"Four":[178],"SD":[179],"maintained":[181],"clinical":[182,228,239],"benefit":[183,240],"25":[186],"Most":[188,202],"treatment-related":[189],"adverse":[190],"events":[191],"(TRAE)":[192],"grade":[194,212,216],"1":[195],"2":[197],"(87%":[198],"unique":[200],"events).":[201],"common":[203],"AEs":[204],"injection":[206],"site":[207],"reactions.":[208],"Eight":[209],"reported":[211],"no":[215],"AEs.":[218],"Survivin-specific":[219],"T-cell":[220],"responses":[221,248],"observed":[223],"treated":[225],"benefit.":[229],"CONCLUSIONS:":[230],"Maveropepimut-S":[231],"intermittent":[233],"low-dose":[234],"well-tolerated,":[237],"Observed":[247],"are":[249],"irrespective":[250],"status.":[254]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4367602020","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":8},{"year":2023,"cited_by_count":2}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2023-05-02T00:00:00"}
